Article Title
Abstract
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reuptake inhibitors in the treatment of depression (1,2). The use of these medications in case of a depressed patient whose condition was resistant to several forms of monotherapy, monotherapy with "standard" augmentation and ECT. After only a partial response to fluoxetine and methylphenidate, bupropion was added, resulting in full, sustained remission.
Recommended Citation
Bobo, William M.D.
(2001)
"Methylphenidate, Bupropion, and SSRI Triple Therapy,"
Jefferson Journal of Psychiatry:
Vol. 16:
Iss.
1, Article 8.
Available at:
http://jdc.jefferson.edu/jeffjpsychiatry/vol16/iss1/8